Victorian Heart Hospital Clinical Trials, formerly known as the Monash Cardiovascular Research Centre, conducts comprehensive clinical trials across all phases (1 to 4) to advance cardiovascular care.
Key areas of focus include:
- Interventional trials: Testing materials and drug coatings for stents and balloons, and enhancing imaging techniques to improve coronary artery disease treatments
- Structural heart trials: Evaluating new materials and devices for valve replacements and repairs, addressing inherited conditions or age-related issues
- Rhythm management trials: Developing cardiac mapping, ablation catheter technologies, and implantable devices for managing atrial fibrillation and ventricular tachycardia
- Pharmaceutical trials: Assessing medications for lipid reduction, glucose regulation, hypertension, and heart failure to reduce cardiovascular event risk
- Cardiothoracic surgery trials: Investigating new medications administered before or after bypass surgery to enhance recovery and prevent future cardiovascular events
Participation in these studies is vital for advancing medicine, developing personalised therapies, and improving future cardiovascular care.
Learn more about participating in a clinical trial.
Asia-Pacific Hub for Cardiovascular Research and Innovation
The Victorian Heart Institute is a leader in cardiovascular innovation, fostering breakthroughs that will improve patient outcomes worldwide.
The Victorian Heart Institute is spearheading the creation of an Asia-Pacific Hub for Cardiovascular Clinical Trials, supported by advanced databases, registries, and biobanks. These initiatives are critical for driving impactful cardiovascular research on a global scale.